Targeted steroid use may offer a universal complementary treatment to fight TB

Tuberculosis (TB) remains a major global health challenge, affecting more than 10 million people annually worldwide, with ...

Macomics Announces Neurodegeneration and Neuroinflammation Applications of ENIGMAC Drug Discovery Platform

Macomics Ltd, a leader in macrophage drug discovery, announces that it has validated its ENIGMAC™ platform in neurodegeneration and neuroinflammation applications. Macomics’ ENIGMAC drug discovery ...
Mathrubhumi English

New study gives fresh hopes in TB treatment: Here's how steroids can improve immune response

A study shows targeted steroid use, like dexamethasone, boosts macrophage function and reduces inflammation, offering ...

Macrophages Protect Insulin-Producing Cells, Preventing Type 1 Diabetes

Researchers have shown how a type of macrophage protects insulin-producing cells in the pancreas from T cells, preventing ...

Resolution Therapeutics announces upcoming presentations at the American Association for the Study of Liver Disease (AASLD) The Liver Meeting® 2025

Resolution Therapeutics Limited ("Resolution" or "Company"), a clinical-stage biopharmaceutical company pioneering Regenerative Macrophage Therapy in inflammatory and fibrotic diseases, today ...
The Morung Express

Targeted steroid use shows promise against TB

Treating patients with steroids may offer a universal complementary treatment to fight tuberculosis (TB) -- affecting more ...

Resolution Therapeutics to present EMERALD study design at the British Association for the Study of the Liver (BASL) annual meeting 2025

Resolution Therapeutics Ltd ("Resolution" or "Company"), a clinical-stage biopharmaceutical company pioneering Regenerative Macrophage ...
Trinity College Dublin

Could targeted steroid use offer a universal complimentary treatment to fight TB?

Researchers wanted to understand how steroids selectively affect human macrophages, which are a key cellular player in the ...